Hematology TimesNICE says CAR T-cell therapy isn’t cost-effectiveAugust 29, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology TimesEC approves CAR T-cell therapy for DLBCL, PMBCLAugust 28, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular LymphomaB Cell Lymphoma
Hematology NewsctDNA predicts early outcomes in DLBCLAugust 27, 2018Aggressive LymphomasLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsFDA approves ibrutinib with rituximab in Waldenström’s macroglobulinemiaAugust 27, 2018Indolent LymphomaLymphoma & Plasma Cell Disorders
Hematology TimesEC approves CAR T-cell therapy for ALL, DLBCLAugust 27, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyALLNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology TimesFDA approves new use for ibrutinib in WMAugust 27, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology NewsElotuzumab under review for relapsed/refractory myelomaAugust 24, 2018Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology TimesStudy reveals ‘complete mental health’ among cancer survivorsAugust 24, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Hematology TimesCombo produces high response rate in CLLAugust 24, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology NewsCombo treatment yields MRD-negative remissions in CLLAugust 23, 2018CLLLeukemia, Myelodysplasia, TransplantationAggressive LymphomasLymphoma & Plasma Cell Disorders
Hematology TimesSignal strength tied to potency of CAR T-cell therapyAugust 22, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology TimesRole of SES in childhood cancer survival disparitiesAugust 21, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsAMLALLHodgkin LymphomaNon-Hodgkin Lymphoma
Hematology TimesAccess to care drives disparity between urban, rural cancer patientsAugust 20, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated IssuesAMLNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesCPI-613 receives orphan designation for PTCLAugust 17, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaB Cell Lymphoma
Hematology NewsHaving prescription drug coverage is associated with improved myeloma outcomesAugust 16, 2018Practice ManagementMultiple MyelomaLymphoma & Plasma Cell DisordersBusiness of Medicine
